Clinical Trial Update: PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2) [Phase 3]

View source ↗

Summary

Phase 3 PRE-SURGE 2 trial completed evaluating a Regeneron investigational therapy to prevent gout flares triggered by urate-lowering drugs; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Investigational Regeneron therapy (PRE-SURGE 2)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2017-04-28